CMC(SH:600327)2022-04-26 16:00Financial Performance - The company's operating revenue for Q1 2022 was ¥858,261,986.88, representing a decrease of 60.02% compared to the same period last year[3]. - The net profit attributable to shareholders was ¥57,257,514.55, down 46.95% year-on-year[3]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥39,513,943.38, a decline of 63.20% compared to the previous year[3]. - Basic and diluted earnings per share were both ¥0.065, down 46.95% year-on-year[3]. - The decline in revenue and profit was primarily due to the disposal of the automotive business and the impact of the newly added medical services[6]. - Total revenue for Q1 2022 was ¥858,261,986.88, a significant decrease of 60% compared to ¥2,146,729,588.54 in Q1 2021[17]. - Net profit for Q1 2022 was ¥69,320,742.86, compared to ¥110,220,453.23 in Q1 2021, indicating a decline of approximately 37%[17]. - The total comprehensive income for Q1 2022 was ¥69,108,867.60, down from ¥77,880,582.80 in Q1 2021, reflecting a decline of approximately 11%[18]. - The basic and diluted earnings per share for Q1 2022 were both ¥0.065, compared to ¥0.122 in Q1 2021, indicating a decrease of 46.7%[18]. Cash Flow - The net cash flow from operating activities was -¥26,218,840.44, reflecting a decrease of 114.37%[3]. - Cash flow from operating activities for Q1 2022 was negative at -¥26,218,840.44, a significant decline from ¥182,410,301.64 in Q1 2021[21]. - Cash inflow from operating activities totaled ¥1,459,197,692.06 in Q1 2022, down 53.7% from ¥3,145,141,803.50 in Q1 2021[21]. - Cash outflow from operating activities was ¥1,485,416,532.50 in Q1 2022, compared to ¥2,962,731,501.86 in Q1 2021, a decrease of 49.9%[21]. - The net cash flow from investing activities was -¥156,026,125.89 in Q1 2022, compared to ¥168,841,535.86 in Q1 2021, indicating a shift towards negative cash flow[22]. - The net cash flow from financing activities for Q1 2022 was -¥220,968,597.09, a decline from positive cash flow of ¥85,823,564.37 in Q1 2021[22]. - The ending cash and cash equivalents balance for Q1 2022 was ¥1,168,196,437.06, down from ¥1,319,555,464.61 in Q1 2021, reflecting a decrease of approximately 11.4%[22]. Assets and Liabilities - Total assets at the end of the reporting period were ¥8,357,139,375.11, an increase of 1.25% from the end of the previous year[3]. - The company's total assets as of March 31, 2022, amounted to ¥8,357,139,375.11, an increase from ¥8,253,970,595.74 at the end of 2021[14]. - Current assets totaled ¥4,102,794,655.46, slightly down from ¥4,111,312,056.17 at the end of 2021[12]. - Inventory increased to ¥2,474,342,746.76 from ¥2,229,129,537.26, representing an increase of approximately 11%[12]. - Current liabilities decreased to ¥3,792,788,423.15 from ¥3,854,841,262.31, a reduction of about 1.6%[13]. - Non-current liabilities rose to ¥572,347,934.35 from ¥481,129,193.34, marking an increase of approximately 19%[14]. - The company's equity attributable to shareholders increased to ¥3,656,513,485.51 from ¥3,599,088,859.93, reflecting a growth of about 1.6%[14]. - The equity attributable to shareholders was ¥3,656,513,485.51, up 1.60% from the end of the previous year[3]. - The company reported a significant increase in long-term receivables, rising to ¥37,863,497.90 from ¥33,470,759.77, an increase of approximately 13%[12]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 42,297[8]. - The net profit attributable to the parent company for Q1 2022 was ¥57,257,514.55, a decrease of 47% compared to ¥107,925,083.91 in Q1 2021[18].